Summary: The Lip TV reports on MAPS’ ongoing clinical trials into MDMA-assisted psychotherapy for treating posttraumatic stress disorder (PTSD), highlighting MAPS as one of the leading organizations helping to promote and fund ongoing psychedelic research.”One of the first things I said when it kicked in was ‘this is what I’ve been looking for.’ I reconnected with myself and did a lot of internal work, and afterwards it was like a huge weight was lifted off my shoulders,” explains MDMA-assisted psychotherapy study participant and military veteran Tony Macie.
Originally appearing here.
MDMA, the active ingredient in molly and ecstasy, may soon be legal as a medical drug for treating PTSD and other anxiety-related conditions. The drug is currently undergoing a series of tests by the Multidisciplinary Association for Psychedelic Studies and is expected to be ready for FDA approval by 2021. Can MDMA be an effective treatment for PTSD, addiction, anxiety, and other mental illnesses? We look at the medical benefits of MDMA on the Lip News with Nik Zecevic and Jo Ankier.